D81.32 Adenosine deaminase 2 deficiency

✓ Billable ICD-10-CM 2026
Open D81.32 in Web App →

The ICD-10-CM code for Adenosine deaminase 2 deficiency is D81.32 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D80-D89: Certain disorders involving the immune mechanism (D80-D89)
Category D81
21 codes (17 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D81.32:

  • Deficiency, deficient › ADA2 (adenosine deaminase 2)
  • Deficiency, deficient › adenosine deaminase (ADA) › type 2
Code Also
  • , if applicable, any associated manifestations, such as:
  • polyarteritis nodosa (M30.0)
  • stroke (I63.-)

Inclusion Terms

  • ADA2 deficiency
  • Adenosine deaminase deficiency type 2

U.S. Hospital Utilization

  • An estimated 75 U.S. inpatient stays in 2023 included D81.32 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Chapter 3 TOC entry

3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3
Reserved for future guideline expansion

Reserved for future guideline expansion ...................................................................................... 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3.Reserved

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial